[Combination therapy of endemic goiter with two different thyroxine/iodine combinations]

Nuklearmedizin. 1998 May;37(3):101-6.
[Article in German]

Abstract

Aim: Of this study was to investigate the extent of thyrotropin (TSH) suppression and volume reduction in combination therapy of endemic goitre. We compared an individually adapted dose of thyroxine with a fixed dose.

Methods: 105 patients of a multicenter study (randomised, single blinded, controlled) received daily a weight-adjusted LT4-dose in combination with 150 micrograms iodide (group A) or a fixed combination of 100 micrograms LT4 plus 100 micrograms iodide (group B), respectively. At the beginning and after 12 weeks TSH-levels and goitre volume were examined.

Results: Although the amount of thyrotropin suppression showed no differences in both groups, there were more patients in the weight-adjusted treatment group with completely suppressed thyrotropin serum concentrations (p < 0.05). Both groups showed a reduction of goitre volume of 24%

Conclusion: A weight-adjusted LT4-dose of 1.4 micrograms/kg body weight often leads to subclinical hyperthyroidism. To obtain low TSH-levels without complete suppression LT4-doses of 1.0 microgram/kg body weight plus 150 micrograms iodide are probably sufficient.

Publication types

  • Clinical Trial
  • English Abstract
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Dose-Response Relationship, Drug
  • Female
  • Goiter, Endemic / drug therapy*
  • Humans
  • Hyperthyroidism / epidemiology
  • Iodine / therapeutic use*
  • Male
  • Single-Blind Method
  • Thyroid Function Tests
  • Thyrotropin-Releasing Hormone
  • Thyroxine / adverse effects
  • Thyroxine / therapeutic use*

Substances

  • Thyrotropin-Releasing Hormone
  • Iodine
  • Thyroxine